The Galien Forum USA 2019

KEYNOTE
1

Co-Chairs
Susan Desmond-Hellmann
Chief Executive Officer
Bill & Melinda Gates Foundation
Prix Galien USA Committee Chair

Scott Gottlieb
Former Commissioner
U.S. FDA

Panel Intro

Innovation and Access


Susan Desmond-Hellmann
Chief Executive Officer
Bill & Melinda Gates Foundation
Prix Galien USA Committee Chair

Sue Desmond-Hellmann, MD, MPH, is CEO of the Bill & Melinda Gates Foundation. Trained as an oncologist, she previously spent 14 years at Genentech developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. In November 2009, Forbes named her one of the world’s seven most “powerful innovators,” calling her “a hero to legions of cancer patients.” In her current role she champions a similar approach to global development: precision public health – getting the right interventions, to the right populations, in the right places, to save lives. Sue was also the first female chancellor of the University of California at San Francisco (UCSF), overseeing all aspects of the university and medical center’s strategy and operations. Sue is the recipient of numerous honors and awards and was listed among Fortune magazine’s “top 50 most powerful women in business” for seven years. In 2010, she was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine. She is a director at Facebook Inc.


Scott Gottlieb
Former Commissioner
U.S. FDA